Patent Assignment
Reel/Frame 047399/0698
Release of Security Interest
Recorded: 2018-11-02
Pages: 14
Assignor
QUANTIUS INC.
Executed: 2018-10-10
Assignees
ACERUS PHARMACEUTICALS CORPORATION
2486 DUNWIN DRIVE, MISSISSAUGA. ONTARIO, L5L 1J9, CANADA
ACERUS LABS INC.
2486 DUNWIN DRIVE, MISSISSAUGA, ONTARIO, L5L 1J9, CANADA
ACERUS BIOPHARMA INC.
2486 DUNWIN DRIVE, MISSISSAUGA. ONTARIO, L5L 1J9, CANADA
Covered Properties
(9)
Controlled Release Topical Testosterone Formulations and Methods
Application:
14/442,949 →
Publication:
US 2015/0297733
Controlled Release Topical Testosterone Formulations and Methods
Application:
14/508,904 →
Methods of Treating Hypogonadism with Intranasal Testosterone Bio-Adhesive Gel Formulations in Male with Allergic Rhinitis, and Methods for Preventing an Allergic Rhinitis Events
Application:
14/536,130 →
Controlled Release Topical Testosterone Formulations and Methods
Application:
14/713,706 →
Publication:
US 2016/0113946
Nasal Cannabidiol Compositions
Application:
15/613,116 →
Publication:
US 2017/0348276
One- and Two-Point Titration Methods to Determine Daily Treatment Regimens to Treat Hypogonadism or Male Testosterone Deficiency with an Intranasal Testosterone Bio-Adhesive Gel
Application:
61/802,724 →
One- and Two-Point Titration Methods to Determine Daily Treatment Regimens to Treat Hypogonadism or Male Testosterone Deficiency with an Intranasal Testosterone Bio-Adhesive Gel
Application:
61/802,727 →
Primary and Secondary Efficacy and Safety Endpoints for Controlled Release Topical Testosterone Gel Formulations and Methods
Application:
61/802,737 →
Primary and Secondary Efficacy and Safety Endpoints for Controlled Release Topical Testosterone Gel Formulations and Methods
Application:
61/802,739 →
Related Assignments
(16)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest
Jul 25, 2014
From: TRIMEL BIOPHARMA SRL
To: MIDCAP FUNDING V, LLC
Reel/Frame 033416/0897 →
Assignment of Assignor's Interest
Oct 9, 2015
From: TRIMEL BIOPHARMA SRL; TRIMEL PHARMACEUTICALS CORP.
To: ACERUS PHARMACEUTICALS SRL
Reel/Frame 036827/0897 →
Assignment of Assignor's Interest
Jun 27, 2017
From: BRYSON, NATHAN; SHARMA, AVINASH
To: ACERUS PHARMACEUTICALS CORPORATION
Reel/Frame 042822/0764 →
Change of Name
Dec 5, 2017
From: ACERUS PHARMACEUTICALS SRL
To: ACERUS BIOPHARMA INC.
Reel/Frame 044693/0936 →
Security Interest
Jan 24, 2018
From: ACERUS BIOPHARMA INC.
To: QUANTIUS INC.
Reel/Frame 044719/0767 →
Security Interest
Jan 24, 2018
From: ACERUS LABS INC.
To: QUANTIUS INC.
Reel/Frame 044719/0876 →
Assignment of Assignor's Interest
Mar 8, 2018
From: ACERUS PHARMACEUTICALS CORPORATION
To: ACERUS LABS. INC.
Reel/Frame 045141/0849 →
Release of Security Interest
Oct 9, 2018
From: MIDCAP FUNDING V TRUST
To: ACERUS PHARMACEUTICALS SRL
Reel/Frame 047207/0254 →
Intellectual Property Security Agreement
Oct 11, 2018
From: ACERUS PHARMACEUTICALS CORPORATION; ACERUS BIOPHARMA INC.; ACERUS LABS INC.
To: SWK FUNDING LLC
Reel/Frame 047217/0760 →
Employment Agreement
May 13, 2021
From: TKACHENKO, NATALIA
To: TRIMEL BIOPHARMA INC.
Reel/Frame 056283/0289 →
Employment Agreement
May 13, 2021
From: TKACHENKO, NATALIA
To: TRIMEL BIOPHARMA INC.
Reel/Frame 056285/0129 →
Employment Agreement
May 13, 2021
From: TKACHENKO, NATALIA
To: TRIMEL BIOPHARMA INC.
Reel/Frame 056284/0111 →
Assignment of Assignor's Interest
May 13, 2021
From: TRIMEL BIOPHARMA SRL; TRIMEL PHARMACEUTICALS CORP.
To: ACERUS PHARMACEUTICALS SRL
Reel/Frame 056233/0589 →
Gudaitis Declaration Supporting Chain of Title
May 13, 2021
From: TRIMEL BIOPHARMA INC.
To: ACERUS BIOPHARMA INC.
Reel/Frame 056252/0740 →
Change of Name
May 13, 2021
From: ACERUS PHARMACEUTICALS SRL
To: ACERUS BIOPHARMA INC.
Reel/Frame 056238/0484 →
Security Interest
Dec 22, 2023
From: ACERUS PHARMACEUTICALS CORPORATION
To: FIRST GENERATION CAPITAL INC.
Reel/Frame 065943/0742 →